The Institute for Neurodegenerative Disorders, founded in 2001, is an independend 501(c)3 nonprofit research institute based in New Haven, Connecticut with the goal of creating a unique clinical research company that combines excellence in clinical neuroscience with state-of-the-art imaging to develop improved tools for the diagnosis and treatment of Parkinson disease, Alzheimer disease and other neurologic conditions.
IND stands as a premier clinical and imaging research facility. A focus of our research is to develop innovative neuroimaging tools to detect neurologic conditions before symptoms appear, make an accurate diagnosis and monitor disease progression. Additionally, IND participates in the evaluation of new symptomatic treatments and the development of medications with the potential of slowing disease progression.
As a non-profit scientific research institute, IND depends on the support of foundations, state and federal grants, corporations and the participation and contributions of individuals in order to carry out its import work. IND does not charge patients for any of its services, including clinical evaluations or educational programs provided by its staff.
We envision a future in which research provides methods of early detection and effective treatment, with the ultimate goal of preventing these neurologic conditions.
Dr. Marek serves as President of IND and was, until March, 2001 Director of the Movement Disorders Center at the Yale University School of Medicine. He graduated from Princeton University (AB, biochemistry), and received his medical degree from Yale University...
Dr. Seibyl serves as CEO and Senior Scientist at IND and was until July 2001 Chief, Section of Nuclear Medicine and Associate Professor of Diagnostic Radiology and Psychiatry, Yale University School of Medicine. He received his undergraduate degree at Yale College and completed his medical degree...
IND's team of expert researchers includes neurologists, a nuclear medicine physician, nurses, study coordinators, neuropsychologists and imaging technologists. Together, we focus on research in the following areas
IND is actively involved in novel clinical studies offering the potential to slow neurological disease or even restore neurological function. This will be accomplished through combining the use of new and innovative imaging techniques with evaluation of treatments aimed at slowing the progression of neurodegeneration. Active research programs are currently available at IND for the following conditions:
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
